I mistakenly posted the response below to a psea post

New Post Public Reply Private Reply Replies (0) Message Board
ClosetInvestor misiu143 #26406
471
I mistakenly posted the response below to a psea post earlier this morning. I’m not sure how that happened, but the message was meant for misiu143, a response to her post #26406 from her yesterday. My apologies psea.

“It look that some group of people absolutely can’t accept that this treatment (hydroxychloroquine) is working with many, especially when started soon...”

You’re a self proclaimed doctor, who has also claimed to have participated in administering clinical trial medications to patients, and you’re asking why investors and health care professionals wont accept a clinically unproven drug for COVID? That’s absurd. You, of anyone, should understand how the FDA works in regards to approving drugs for certain indications. Yes, doctors talk amongst themselves and share preliminary results, but that talk is not meant for the general population and isn’t considered FACTs until proven by an official study. Dr. Fauci, the CDC, and the FDA are treating hydroxychloroquine like every other potential COVID treatment until a study shows efficacy: an unproven drug for the indication. And, of any drug for COVID patients, hydroxychloroquine needs further research because of the trials from China and around the world that have shown very different results.

“We all know why I believe ...”

I’m not sure what answer is possible because you personally aren’t prescribing the medication to COVID patIents and there isn’t an FDA approved trial showing efficacy. There is only anecdotal data that varies widely in efficacy.

Media and social media platforms are dangerous with disinformation in regards to COVID19 and treatments. I came across a video from a “Dr.” yesterday on social media that was discussing preventions and treatment for COVID19. This video had over 100K views. The “Dr.” was discussing notes he’d gotten from another Dr at an urgent care that showed promising results with early anti-biotic treatment. This “Dr.” then started discussing alternative treatments and prevention, including drinking tonic water everyday to prevent one from contracting COVID. After a little research, I discovered this “Dr.” is actually a chiropractor and is the owner of a wellness center. He didn’t mention this In the video, but from the comments, people were widely supporting his unsupported claims.

This is dangerous and people on social media are making similar videos and claims about hydroxychloroquine. I want to keep this non-political and consider myself in the middle on politics (more apolitical than anything), but I’d like to point out that the majority of individuals really pushing hydroxychloroquine are conservative and have ZERO medical knowledge. Like why’s, those who really bash the medication tend to be liberals. The topic of hydroxychloroquine and COVID should’ve never become political and should’ve been left to doctors and researchers, but unfortunately like every aspect of life today, politicians politicize everything for personal and political gain.
1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lyric Health's AI System Promises Data-Driven Revolution

Updated Category News Views 7

A Bold Step in Healthcare Coordination No doubt about it, healthcare is a mess. It's like trying to patch a leaking ship with duct tape—point solutions here, add-ons there, and nothing truly working in harmony. And in storms in Lyric Health, claiming they've got the answer. They've launched an AI-powered Healthcare Operating System meant to unify these disjointed pieces...

Continue Reading
2026 CEE Awards Highlight Energy Innovation Leaders

Updated Category News Views 7

Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...

Continue Reading
Jacob Walthour to Be Honored for Economic Leadership

Updated Category News Views 8

The Honoring of Leadership That Goes Beyond Business In a world where financial influence often feels like it funnels into the same familiar pockets, the news of Jacob Walthour Jr.'s upcoming recognition feels like a fresh breeze of change. The Alpha Phi Alpha's Alpha Alpha Lambda Chapter is rolling out the red carpet at its Centennial Gala for Walthour, throwing him into...

Continue Reading
Red Banyan Earns Top Honors in Florida for 2026

Updated Category News Views 8

Red Banyan: A Powerhouse in Reputation Management Boy, have you ever watched a company rise through the ranks almost like a caffeine kick on a drowsy morning? That's Red Banyan for you. This outfit, right out of Fort Lauderdale, snagged the '2026 Best of Florida' award as the cream of the crop in the Business Consulting Firms category. It’s like taking home an Oscar in...

Continue Reading
B2B Growth Hinges on Narrative Coherence, Study Shows

Updated Category News Views 7

Clear Stories, Stronger Growth If companies can't tell a clear story that their buyers understand and believe, they're destined to stagnate. That's the blunt reality kompeld is pushing with their H2 2026 Narrative Coherence Benchmark. The report scores 150 B2B tech companies on their narrative coherence, showing there's a stark correlation between storytelling and growth....

Continue Reading
OrthoAtlanta Expands with Dr. Smith's Expertise Hire

Updated Category News Views 5

OrthoAtlanta Welcomes New Orthopedic Surgeon In a world where healthcare organizations are constantly stretching their wings, this new addition of Dr. Carson J. Smith to the fold at Piedmont Orthopedics | OrthoAtlanta stands out. This isn't just some cosmetic face-lift, folks. It's a real investment in the community, not to mention a crucial broadening of what this...

Continue Reading
Medicare Competitive Bidding May Slash Jobs, Access

Updated Category News Views 5

Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...

Continue Reading
Finastra Recognized as 2026 Leader in Payment Platforms

Updated Category News Views 8

Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...

Continue Reading
Koogler's Sale to ALL4: A Game-Changer for the Southeast

Updated Category News Views 6

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...

Continue Reading
ScholarShare 529 Launches $50 Back-to-School Promo

Updated Category News Views 7

California Families Get a Boost With New 529 Plan Offer Everywhere you turn, it's 'back to school' mania right now, and ScholarShare 529 aims to ride that wave by sweetening the pot for parents ready to think ahead. So here's the gist—California's official college savings plan is handing out a $50 gift card for new accounts opened between now and September 30th. Setting...

Continue Reading

Top 5 Most Recently Viewed Articles

Duke Robotics Expands Presence with New Subsidiary in Greece

Updated Category News Views 118

Duke Robotics Strengthens Market Position with New Greek Subsidiary Duke Robotics Corp. (OTCQB:DUKR) has recently taken a significant step to amplify its presence in the civilian market by establishing Duke Robotics Hellas I.K.E. in Greece. This strategic move is poised to broaden the Company's operational landscape and enhance its capabilities to cater to emerging...

Continue Reading
Transforming Global Payments: How TransFi's BizPay Innovates Business Transactions

Updated Category News Views 272

TransFi's BizPay: A Game Changer in Global Payments TransFi has introduced BizPay, a cutting-edge payment platform designed for swift, compliant cross-border transactions utilizing AI-powered technology. In today's dynamic financial landscape, navigating global payments can often feel daunting due to differing time zones, various banking systems, and complex regulations....

Continue Reading
MicroTech Awarded Major Contract in Federal Print Services

Updated Category News Views 267

MicroTech Secures Significant Contract with Government Agency MicroTech, a prominent player in innovative IT solutions, has recently announced a major achievement, securing a contract from the Government Printing Office (GPO) that falls under the noteworthy D951-M program. This contract allows MicroTech to provide comprehensive managed print services, which encompass...

Continue Reading
MemryX's MX4 Roadmap: Pioneering Efficient AI Data Centers

Updated Category News Views 142

MemryX Introduces the MX4 Roadmap MemryX Inc., a company dedicated to accelerating production AI inference, has unveiled its strategic roadmap for the MX4. This next-generation accelerator aims to extend the company’s unique "at-memory" dataflow architecture from edge applications into larger data center environments. By leveraging advanced 3D hybrid-bonded memory,...

Continue Reading
Microsoft's Dividend Boost and Buyback Strategy Leads to Growth

Updated Category News Views 110

Microsoft's Strategic Financial Moves Recently, Microsoft Corporation (NASDAQ: MSFT) made waves by announcing a significant increase in its quarterly dividend and a new share repurchase program. Following the news, Deutsche Bank reaffirmed its Buy rating on Microsoft’s stock and set a price target of $475. This move to raise the dividend by 10.7%, from $0.75 to $0.83...

Continue Reading